Aralez Bio Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$12M
- Investors
-
13
Aralez Bio General Information
Description
Developer of noncanonical amino acid designed to make products sustainably. The company specializes in inventing an enzymatic method for synthesizing noncanonical amino acids (NCAAs), also called unusual or unnatural amino acids, and the proprietary approach allows NCAAs to be synthesized with enantiopurity in a step, enabling clients to access amino acids that are needed for innovations in pharmaceuticals, agriculture, and functional materials.
Contact Information
Website
www.aralezbio.comCorporate Office
- 1933 Davis Street
- Suite 235
- San Leandro, CA 94577
- United States
Corporate Office
- 1933 Davis Street
- Suite 235
- San Leandro, CA 94577
- United States
Aralez Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 12-Feb-2026 | $12M | Completed | Generating Revenue | ||
| 3. Seed Round | 22-Aug-2022 | Completed | Generating Revenue | |||
| 2. Grant | 26-Jul-2019 | $25K | Completed | Startup | ||
| 1. Accelerator/Incubator | 12-Jun-2019 | Completed | Startup |
Aralez Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed 4 | ||||||||
| Seed 3 | ||||||||
| Seed 2 | 2,131,286 | $0.000100 | $0.94 | $0.94 | 1x | $0.94 | 6.47% | |
| Seed 1 | 2,277,812 | $0.000100 | $0.51 | $0.51 | 1x | $0.51 | 6.91% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Aralez Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aralez Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aralez Bio Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EQS Group | PE-Backed Company | Minority | ||
| Fifty Years | Venture Capital | Minority | ||
| Heritage Medical Systems | Corporation | Minority | ||
| Paladin Capital Group | Venture Capital | Minority | ||
| Spero Ventures | Venture Capital | Minority |
Aralez Bio FAQs
-
When was Aralez Bio founded?
Aralez Bio was founded in 2019.
-
Where is Aralez Bio headquartered?
Aralez Bio is headquartered in San Leandro, CA.
-
What is the size of Aralez Bio?
Aralez Bio has 40 total employees.
-
What industry is Aralez Bio in?
Aralez Bio’s primary industry is Drug Discovery.
-
Is Aralez Bio a private or public company?
Aralez Bio is a Private company.
-
What is the current valuation of Aralez Bio?
The current valuation of Aralez Bio is .
-
What is Aralez Bio’s current revenue?
The current revenue for Aralez Bio is .
-
How much funding has Aralez Bio raised over time?
Aralez Bio has raised $24M.
-
Who are Aralez Bio’s investors?
EQS Group, Fifty Years, Heritage Medical Systems, Paladin Capital Group, and Spero Ventures are 5 of 13 investors who have invested in Aralez Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
